Aleva Neurotherapeutics SA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Aleva Neurotherapeutics SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6386
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aleva Neurotherapeutics SA (Aleva) is a medical device company that provides neuro-stimulation solutions. The company’s products include deep brain stimulation diagnostic systems and deep brain stimulation systems. Its deep brain stimulation systems provide directional stimulation for more precise area of the brain to be activated. Aleva’s deep brain stimulation diagnostic systems offer surgeries that first finds brain region using electrophysiological recordings. The company also provides micro system technologies that contain therapies that are optimized for effectiveness in each disease and individual patient and unique micro-fabricated devices enabling target specific stimulation. It offers its products across Switzerland. Aleva is headquartered in Lausanne, Switzerland.

Aleva Neurotherapeutics SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Aleva Neurotherapeutics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Aleva Neurotherapeutics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Aleva Neurotherapeutics SA, Medical Equipment, Deal Details 10
Venture Financing 10
Aleva Neurotherapeutics Raises USD13 Million in Series D Financing 10
Aleva Neurotherapeutics Raises USD18 Million in Series C Financing Round 11
Aleva Neurotherapeutics to Raise Funds in Series C Financing 13
Aleva Neurotherapeutics Raises US$4.3 Million In Series B Financing 14
Partnerships 15
Aleva Neurotherapeutics Enters into Agreement with Greatbatch 15
Aleva Neurotherapeutics SA – Key Competitors 16
Aleva Neurotherapeutics SA – Key Employees 17
Aleva Neurotherapeutics SA – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Apr 24, 2018: Aleva Neurotherapeutics Strengthens Senior Management Team with Appointment of Two Industry Veterans 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Aleva Neurotherapeutics SA, Medical Equipment, Key Facts 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Aleva Neurotherapeutics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Aleva Neurotherapeutics SA, Deals By Market, 2012 to YTD 2018 8
Aleva Neurotherapeutics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Aleva Neurotherapeutics Raises USD13 Million in Series D Financing 10
Aleva Neurotherapeutics Raises USD18 Million in Series C Financing Round 11
Aleva Neurotherapeutics to Raise Funds in Series C Financing 13
Aleva Neurotherapeutics Raises US$4.3 Million In Series B Financing 14
Aleva Neurotherapeutics Enters into Agreement with Greatbatch 15
Aleva Neurotherapeutics SA, Key Competitors 16
Aleva Neurotherapeutics SA, Key Employees 17

List of Figures
Aleva Neurotherapeutics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Aleva Neurotherapeutics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Aleva Neurotherapeutics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Aleva Neurotherapeutics SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Aleva Neurotherapeutics SA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Immuron Ltd (IMC):企業の財務・戦略的SWOT分析
    Summary Immuron Ltd (Immuron), formerly Anadis Ltd is a biopharmaceutical company that develops oral immunotherapy therapeutics using polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. It pro …
  • EyeGate Pharmaceuticals Inc (EYEG)-医療機器分野:企業M&A・提携分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical company that offers eye care medicines. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient a …
  • EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報
    Summary EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and med …
  • Triangle Energy (Global) Ltd (TEG):石油・ガス:M&Aディール及び事業提携情報
    Summary Triangle Energy (Global) Ltd (Triangle Energy), formerly Maverick Energy Ltd, is an oil and gas company that explores and produces oil and natural gas reserves. The company operates oil and gas assets such as Reid’s Dome and Pase Field. It holds working interest and operates the Production S …
  • Concept Life Sciences Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Concept Life Sciences Ltd (Concept Life Sciences), formerly Peakdale Molecular Ltd, a subsidiary of Concept Life Sciences Holdings Ltd is a provider of integrated discovery and development solution. The company services include integrated drug discovery and development services and analytica …
  • Shree Rama Newsprint Limited (RAMANEWS):企業の戦略的SWOT分析
    Shree Rama Newsprint Limited (RAMANEWS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Storebrand ASA:戦略・SWOT・企業財務分析
    Storebrand ASA - Strategy, SWOT and Corporate Finance Report Summary Storebrand ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tianjin Chase Sun Pharmaceutical Co Ltd (300026):製薬・医療:M&Aディール及び事業提携情報
    Summary Tianjin Chase Sun Pharmaceutical Co Ltd (Chase Sun) is a medicine and health industry group. The company research, develops, produces, and markets various pharmaceutical products. It offers products such as Chinese herb preparations, Chinese medicinal granules, synthetic drugs, biotech drugs …
  • Ardelyx Inc (ARDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company provides product portfolio such as tenapanor, RDX227675, RDX98940 and RDX013, among others. Its products are used for hyperphosphatemia in …
  • Palred Technologies Limited:戦略・SWOT・企業財務分析
    Palred Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Palred Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Damco International A/S:戦略・SWOT・企業財務分析
    Damco International A/S - Strategy, SWOT and Corporate Finance Report Summary Damco International A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Microsoft Corporation (MSFT)-医療機器分野:企業M&A・提携分析
    Summary Microsoft Corporation (Microsoft) is a technology-based company that develops, licenses, and supports software products, services, and devices. The company offers a comprehensive range of operating systems, cross-device productivity applications, server applications, business solution applic …
  • SAES Getters SpA (SG):企業の財務・戦略的SWOT分析
    SAES Getters SpA (SG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Delphi Energy Corp (DEE):企業の財務・戦略的SWOT分析
    Delphi Energy Corp (DEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Chong Kun Dang Pharmaceutical Corp (185750):製薬・医療:M&Aディール及び事業提携情報
    Summary Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for …
  • Newfield Exploration Co (NFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Newfield Exploration Co (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The company …
  • Ortivus AB (ORTI B):企業の財務・戦略的SWOT分析
    Summary Ortivus AB (Ortivus) is a supplier of mobile solutions for emergency medical care. The company develops and offers cardiology, and mobile monitoring and communication solutions. Its products include MobiMed Smart, CoroNet, excense heart record system and excense decision support healthcare s …
  • RWE AG (RWE):企業の財務・戦略的SWOT分析
    RWE AG (RWE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Natural Capsules Ltd (524654):企業の財務・戦略的SWOT分析
    Natural Capsules Ltd (524654) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆